Skip to main navigation Skip to search Skip to main content

Integrating technology to increase the reach of CBT-I: state of the science and challenges ahead

Research output: Contribution to Journal › Article › Academic › peer-review

103 Downloads (Pure)

Abstract

In this Round Table Discussion, an international panel of experts discuss issues related to the use of technology in the delivery of cognitive behavioral therapy for insomnia (CBT-I), in order to increase its reach. Panelists were, in alphabetical order, Carmela Alcántara, PhD, an Associate Professor at Columbia University School of Social Work in New York, USA, Bei Bei, PhD., an Associate Professor at Monash University in Melbourne, Australia, Charles M. Morin, PhD., a Professor of Psychology at Laval University in Quebec City, Canada, and Annemieke A. van Straten, PhD., a Professor of Clinical Psychology at the Vrije Universiteit in Amsterdam, the Netherlands. The session was chaired by Rachel Manber, PhD., a Professor of Psychiatry and Behavioral Sciences at Stanford University, in Palo Alto, California, USA. In their introductions each panelist discussed the use of technology in their respective country. All indicated that the most common way technology is used in the treatment of insomnia is through the use of video calls (telemedicine) to deliver individual CBT-I, and that this is mostly covered by publicly funded health insurance programs such as Medicare, especially since the COVID-19 pandemic. There are also some fully automated insomnia treatment programs, but they're often not covered by Medicare or other health insurance programs.

Original languageEnglish
Article numberzsac252
Pages (from-to)1-3
Number of pages3
JournalSleep
Volume46
Issue number1
Early online date29 Oct 2022
DOIs
Publication statusPublished - Jan 2023

Bibliographical note

Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: [email protected].

Funding

This work was sponsored by Pear Therapeutics. Pear Therapeutics has had no influence on the opinions or views of either the moderator or the speakers. None of the participants in the Roundtable has received payments from Pear Therapeutics or any third party (including Oxford University Press) to take part in this activity.

Funders
Pear Therapeutics

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Integrating technology to increase the reach of CBT-I: state of the science and challenges ahead'. Together they form a unique fingerprint.

    Cite this